Results from a mouse model of CD showed that treatment with anti-4-1BB monoclonal antibodies seemed to have an anti-inflammatory effect in the colon and increased proportions of splenic CD8+ T cells (32). The gene discussed is CD8A; the disease is Cowden disease.